Ebos GroupTurnover at medical consumable and pharmaceutical products company Ebos Group has grown from around $8 million to $6 billion in the 27 years since Mark Waller became CEO.

Pumpkin Patch shares hit another record low yesterday as investors continued to punish the company after a dark annual meeting.

Orion Health has made an impressive sharemarket debut, but analysts say the software developer has a big job ahead in pulling off its ambitious growth targets.

Shares in Orion Health have risen 14% above the offer price following the software developer's sharemarket debut this morning.

Fisher & Paykel Healthcare shares have soared to a record high after the medical device maker's sixth profit guidance upgrade in two years.

New Zealand shares rose as Fisher & Paykel Healthcare advanced to a record after lifting its annual profit guidance. Xero fell as its first-half results showed a slower pace of growth.

When Mark Waller took over the top job at listed healthcare supplier Ebos, he never imagined he'd be dropping the reins 27 years later.

What are the top 10 worst performing shares of 2014 so far? Find out with a graphic showing the biggest losers.

Fund managers have expressed concern over Orion Health's unusual decision to not provide earnings forecasts ahead of its highly anticipated initial public offer, which will raise up to $150 million in new growth capital.

Check out a snapshot of some of the stellar performers on the New Zealand sharemarket this year, as it surged ahead breaking new records.

NZ exporters will have better access to up to more than $2 trillion worth of government contracts, with a trade deal signed two years ago expected to come into force soon.

Fisher & Paykel Healthcare has become a $3 billion company after its ballooning share price hit a record high.

Recent issues of Orion Health Group shares to private investors provide clues to the issue price in its upcoming initial public offer.

The ink is barely dry on the announcement of Orion Health's up to $150m sharemarket listing and fund managers are already talking down the offer's price - even though it is yet to be revealed.

Health technology company Orion Health, which is expected to list this year, has signed a new deal to work with the Waitemata District Health Board, starting with two wards at Auckland's North Shore Hospital.

Technology has come a long way since Fisher & Paykel Healthcare made its first air humidifier prototype using an AG preserving jar and the company is working hard to stay at the forefront of respiratory technology.

The NZX will run out of steam unless companies, particularly the larger ones, can take advantage of the stronger economy, writes Brian Gaynor.

Innovation is continuing to bolster Fisher & Paykel Healthcare's business in the face of a stubbornly high New Zealand dollar, says chief executive Mike Daniell.

Ebos Group's $1.1 billion acquisition of Australian firm Symbion this week again highlighted an ongoing issue with getting independent research on NZX-listed companies.

The contrasting fortunes of two of New Zealand's biggest technology manufacturers were highlighted when they both reported full-year results yesterday.